miRNA MiRxes to Expand miRNA Assay Technology to Multiple Cancer Types, Other Disease Areas Premium The firm said it has long-term plans to launch multiple miRNA screening tests for cancers that would run in labs or at the point of care using one blood sample. Preferred Medicine Building Data for Breast Cancer MicroRNA Screening Test Premium The company is working with three institutions to recruit about 1,200 case-control participants for its validation study, with plans to launch an LDT next year. Lithuanian Team Developing Droplet-Based Single-Cell Small RNA Sequencing Approach Premium The European Union has backed the project, called Droplet-Small-Seq, with a €146,000 Horizon 2020 research grant. COVID-19 Severity Linked to mRNA, lncRNA Signature in Blood The researchers said that more research into these biomarkers could help with patient stratification and therapy selection. Singapore's MiRxes Sets Out to Sell Gastric Cancer Test Across Asia Premium The assay underwent clinical validation at three centers in Singapore and 5,248 patients were ultimately screened using the test. Oct 22, 2020 Summit Biolabs Commercializing Tests for Head and Neck Cancer Recurrence, COVID-19 Premium Sep 15, 2020 Quadrant Biosciences Wins $2.3M NIH Grant to Develop Saliva Test for Concussion Jul 9, 2020 Integrated Proteomic Papers Define Lung Cancer Features Across Populations, Smoking Histories May 11, 2020 Genetic Ancestry Linked to Differences in Molecular Features of Cancers Apr 6, 2020 MiR Scientific Validates Urine-Based Cancer Tests, Awaits NY State Approval Premium Mar 5, 2020 Blood-Based MicroRNA Signatures Can Distinguish Individuals With Lung Cancer Dec 18, 2019 ALS Genomic Analysis Highlights Potential MicroRNA Contributor Nov 21, 2019 DiamiR Wins $492K Grant for Alzheimer's Disease Dx Research Oct 10, 2019 FYR Diagnostics Wins $618K NIH Grant to Develop Acquired Epilepsy Assay Sep 30, 2019 Interpace Diagnostics Signs Thyroid Cancer Test Coverage Deals With Three BCBS Plans Sep 19, 2019 Inex Innovate to Launch New Molecular Tests for Ovarian Cancer, Breast Cancer in Asia Premium Sep 16, 2019 Alzheimer's Disease Test Firm DiamiR Awarded Additional $345K From NIA Aug 29, 2019 Notre Dame Team Wins $2.9M NIH Grant for ExRNA Analysis Platform Aug 13, 2019 Interpace Diagnostics Q2 Revenues Climb 14 Percent Jul 30, 2019 Pan-Cancer Study Uncovers TP53 Mutation Consequences, Related Prognostic Expression Signature Jul 16, 2019 Arcis Licenses Sample Prep Technology to microRNA Diagnostics Firm Mirnax Biosens Jul 12, 2019 Avalon GloboCare Using Exosome Isolation Platform to Pursue Oral Cancer Dx, Rx Applications Premium Jul 2, 2019 Noninvasive Endometriosis Test Developer DotLab Secures $10M in Series A Funding Jun 17, 2019 Q BioMed Using MicroRNA Biomarkers to Guide Therapy Development in Subset of Autism Patients Premium Apr 25, 2019 Colon Cancer Biology, Treatment Clues Found in Proteogenomic Analysis Load More Breaking News In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Parse Biosciences Partners With Research Instruments for Southeast Asia Distribution The Scan Transplant Tests Edited Pig Kidneys The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient. UK Changes Some Gene-Edited Crop Rules A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says. Pill Works Against Omicron in Lab Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports. Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.